Source: The Lancet

Expression of concern: Hydroxychloroquine or chloroquine
with or without a macrolide for treatment of COVID-19:
a multinational registry analysis.

Important scientific questions have been raised about
data reported in the paper by Mandeep Mehra et al—
Hydroxychloroquine or chloroquine with or without a
macrolide for treatment of COVID-19: a multinational
registry analysis (1) – published in The Lancet on May 22, 2020

Although an independent audit of the provenance
and validity of the data has been commissioned by the
authors not affiliated with Surgisphere and is ongoing,
with results expected very shortly, we are issuing an

Expression of Concern to alert readers to the fact that
serious scientific questions have been brought to our
attention. We will update this notice as soon as we have
further information.
The Lancet Editors

The Lancet, London EC2Y 5AS, UK

(1)

Mehra MR, Desai SS, Ruschitzka F, Patel AN. Hydroxychloroquine or
chloroquine with or without a macrolide for treatment of COVID-19:
a multinational registry analysis. Lancet 2020; published online May 22.
https://doi.org/10.1016/S0140-6736(20)31180-6


Related: LancetGate: Surgisphere – is the company which provided the data to the study serious?

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »

Another New York State Supreme Court Justice Ivermectin Order Helping 81-Year-Old Farmer

Ivermectin, a medicine for parasites, has been around for four decades. While not authorized for use against COVID-19, dozens of studies show materially positive results. At well-established human dosage levels, the drug is safe: hundreds of millions of people are treated with it every year mostly in the tropics for various parasite-borne diseases, such as River Blindness in Nigeria.

Read More »

The Chloroquine Wars Part XIII -A Clockwork Orange Man

Immediately following HCQ’s Trump moment, the media went on an all-out blitz to associate the topic of HCQ with a sense of fear. Fear of Trump, fear of death, fear of incompetence, fear of opposing scientific authorities, fear of using medicine needed by somebody else, and fear of the unknown. And the campaign of fear didn’t stop there.

Read More »